Endurant Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,982
| Closed | -$1.82M | – | 76 |
|
|
2022
Q1 | $1.82M | Buy |
+6,982
| New | +$1.82M | 0.48% | 40 |
|
|
2021
Q3 | – | Sell |
-7,553
| Closed | -$1.52M | – | 64 |
|
|
2021
Q2 | $1.52M | Buy |
+7,553
| New | +$1.52M | 0.42% | 51 |
|
|
2017
Q4 | – | Sell |
-21,900
| Closed | -$3.33M | – | 89 |
|
|
2017
Q3 | $3.33M | Buy |
+21,900
| New | +$3.33M | 1.01% | 33 |
|
|
2016
Q4 | – | Sell |
-5,150
| Closed | -$449K | – | 89 |
|
|
2016
Q3 | $449K | Sell |
5,150
-1,100
| -18% | -$95.9K | 0.17% | 77 |
|
|
2016
Q2 | $538K | Sell |
6,250
-2,500
| -29% | -$215K | 0.18% | 73 |
|
|
2016
Q1 | $696K | Sell |
8,750
-9,500
| -52% | -$756K | 0.23% | 63 |
|
|
2015
Q4 | $2.3M | Sell |
18,250
-8,450
| -32% | -$1.06M | 0.77% | 42 |
|
|
2015
Q3 | $2.78M | Sell |
26,700
-6,200
| -19% | -$646K | 0.93% | 39 |
|
|
2015
Q2 | $4.06M | Buy |
32,900
+18,500
| +128% | +$2.28M | 1.2% | 30 |
|
|
2015
Q1 | $1.7M | Buy |
14,400
+3,600
| +33% | +$425K | 0.56% | 57 |
|
|
2014
Q4 | $1.28M | Buy |
+10,800
| New | +$1.28M | 0.5% | 55 |
|